The reported prevalence of occupational allergy to natural rubber latex is 8% to 17%, and that of latex-induced occupational asthma is 2.5% to 6%. Conversion of medical facilities to « latex-safe » can reduce employee sensitization, impairment, and disability.
The purpose of this study was to determine the cost of a latex-safe approach, compared with that of continued latex glove use, and to identify the level of worker disability required to make the latex-safe approach financially preferable to a health care institution.
The costs of 2 strategies-latex-safe vs the status quo-were calculated from the perspective of 3 health care institutions.
A break-even point was calculated for each facility.
In all facilities, the cost of using nonlatex gloves exceeded the cost of using latex gloves.
In all 3 facilities, however, 1% or fewer of those at risk would have to become fully disabled or fewer than 2% would have to become partially disabled for the continued use of latex gloves to exceed the cost of the latex-safe approach.
Health care facilities, regardless of size, are likely to benefit financially from becoming latex-safe even if latex-related disability levels are extremely low.
Mots-clés Pascal : Asthme, Allergie, Complication, Latex, Homme, Personnel sanitaire, Evolution, Incapacité travail, Analyse coût, Economie santé, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, Appareil respiratoire pathologie, Bronchopneumopathie obstructive, Immunopathologie
Mots-clés Pascal anglais : Asthma, Allergy, Complication, Latex, Human, Health staff, Evolution, Work disability, Cost analysis, Health economy, United States, North America, America, Epidemiology, Respiratory disease, Obstructive pulmonary disease, Immunopathology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0392848
Code Inist : 002B30A01C. Création : 22/03/2000.